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Abstract— The worldwide spread of coronavirus disease 
(COVID-19) has become a threatening risk for global public 
health. It is of great importance to rapidly and accurately screen 
patients with COVID-19 from community acquired pneumonia 
(CAP). In this study, a total of 1658 patients with COVID-19 and 
1027 patients of CAP underwent thin-section CT. All images 
were preprocessed to obtain the segmentations of both infections 
and lung fields, which were used to extract location-specific 
features. An infection Size Aware Random Forest method 
(iSARF) was proposed, in which subjects were automated 
categorized into groups with different ranges of infected lesion 
sizes, followed by random forests in each group for classification. 
Experimental results show that the proposed method yielded 
sensitivity of 0.907, specificity of 0.833, and accuracy of 0.879 
under five-fold cross-validation. Large performance margins 
against comparison methods were achieved especially for the 
cases with infection size in the medium range, from 0.01% to 
10%. The further inclusion of Radiomics features show slightly 
improvement. It is anticipated that our proposed framework 
could assist clinical decision making. 
Index Terms—COVID-19; Pneumonia; Decision tree; Size 
aware; Random forest  
I. INTRODUCTION 
As known as COVID-19, coronavirus disease outbreaks in 
Wuhan, China since Dec. 2019, and rapidly spreads 
nationwide and globally[1, 2]. As a form of pneumonia, the 
infection causes inflammation of air sacs in one or both lungs 
and fills with fluid or pus, making the patient difficult to 
breathe. According to recent report, its lethal rate reaches 
2%[3], second only to Severe Acute Respiratory Syndrome 
(SARS) of 10% and Middle East Respiratory Syndrome 
(MERS) of 36%[4, 5]. Also, it could transmit from person to 
person with a relatively high basic reproduction number (R0) 
of 2.2, and has no efficient treatments and control strategies 
till now[6]. Therefore, screening of COVID-19 out of 
community acquired pneumonia (CAP) is important for 
patient triage, treatment protocol design, and follow-up 
evaluation.  
Currently, a patient, showing respiratory symptoms, fever, 
cough, dyspnea, or pneumonia, would be referred to the test 
of real-time Polymerase Chain Reaction (RT-PCR) for the 
final diagnosis of COVID-19[7]. However, recent studies 
show that RT-PCR has relatively low detection rate at around 
30-60%[8, 9], and repeated tests are generally needed. 
Therefore, negative results of RT-PCR could not rule out the 
possibility of infection. Chest CT is a routine diagnostic tool 
for pneumonia, and is found very useful in detecting typical 
radiographic features of COVID-19, especially with thin 
slices[8, 10]. Basically, these features include bilateral and 
peripheral ground-glass and also consolidative pulmonary 
opacities. According to the time course of disease 
development, patients could be divided into mild, moderate, 
severe and critically ill stages[11]. In the mild stage, almost 
no pneumonia could be seen from CT images. From common 
to critically ill stages, one could observe ground-glass opacity 
(GGO), increased crazy-paving pattern, and consolidation[8]. 
If the symptom of patient improves, gradual resolution of 
consolidation could be seen in CT images. However, it 
remains a great challenge in screening of COVID-19 from 
typical vital pneumonia in CT images. First, same 
radiographic features presenting similar appearances to other 
types of pneumonia, makes it difficult to differentiate from 
each other. Second, CT images, especially for thin slice 
acquisition, contain hundreds of slices for manual checking, 
which is time-consuming and may produce false negative 
results especially at the mild disease stage. Accordingly, an 
automated image analysis method for classifying COVID-19 
from CAP is highly desired. 
Although there are a number of researches summarizing 
typical CT radiographic signs in COVID-19 patients for 
guiding clinical practice, the study on automated machine 
learning assisted disease screening is still limited. For 
example, Wang et al. proposed a deep learning method to 
classify the patches of infected lesions into COVID-19 or 
typical viral pneumonia of totally 99 subjects, where 
manually labeled infections were required [12]. Xu et al. 
studied the early screening of COVID-19 from Influenza-A 
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viral pneumonia and healthy cases with totally 618 CT 
samples[13], where lesion patches were extracted and 
combined with relative distance-from-edge features for 
diagnosis. Li et al. proposed to a 2D model to extract features 
from 2D slices and combined to provide diagnosis of 468 
COVID-19, 1511 CAP, and 1303 non-pneumonia patients.  
Another difficulty in differentiating COVID-19 patients 
from CAP patients is the vast difference of distribution of 
disease stages in the available data. For COVID-19, the stages 
from mild condition to critically ill almost evenly distributed 
in the population of COVID-19 patients. However, for CAP, 
most cases remain in mild to intermediate degree of 
pneumonia as observed in CT images. The main reason could 
be that there are already effective treatments available for 
CAP while not for COVID-19 yet. This leads to inconsistent 
distribution of disease severity in the acquired dataset where 
small infections found in CT images are most likely 
belonging to CAP, while wide spread infections found in CT 
images are for COVID-19. A general classification algorithm 
may take advantage of this situation and report an overall high 
performance result, but may have low sensitivity and 
specificity in the middle range where the infection size is not 
too small or too large, which helps little for doctors in clinical 
practice. This is mainly because the effect of the size of 
infection has not been evaluated and properly considered in 
the classification algorithm.  
In this paper, we propose a machine learning approach for 
screening COVID-19 out of CAP. Our contributions are 3-
folds. 1) We presented an infection size-aware method, and 
broke down the evaluation of COVID-19 classification task 
into multiple infection size ranges, respectively. 2) We 
proposed a location-specific feature extraction process, where 
COVID-19 features were collected and tailored according to 
current understanding of radiographic appearance. 3) The 
proposed method was throughout evaluated on a large-scale 
dataset from multiple centers, covering patients with age 
ranging from 12 to 98 years. Details are provided in the 
following sections.  
II. MATERIALS AND METHODS 
A. Participants and image acquisition  
CT images of a total of 2685 participants were 
retrospectively collected. In this dataset, 1658 cases were the 
confirmed COVID-19 cases diagnosed by positive nucleic 
acid testing with conformation by national CDC. The other 
1027 cases were CAP patients. Three hospitals were involved, 
including Tongji Hospital of Huazhong University of Science 
and Technology, Shanghai Public Health Clinical Center of 
Fudan University, and China-Japan Union Hospital of Jilin 
University.  
All patients underwent chest CT scans with thin section. 
Specifically, CT scanners include uCT 780 from UIH, 
Optima CT520, Discovery CT750, LightSpeed 16 from GE, 
Aquilion ONE from Toshiba, SOMATOM Force from 
Siemens, and SCENARIA from Hitachi. CT protocol 
includes: 120 kV, reconstructed CT thickness ranges from 
0.625 to 2mm, with breath hold at full inspiration. All images 
were de-identified before sending for analysis. The study was 
approved by the Institutional Review Board of participating 
institutes. Written informed consent was waived due to the 
retrospective nature of the study. A mediastinal window (with 
window width 350 HU and window level 40 HU) and lung 
window (with window width 1200 HU and window level-600 
HU) were used for reading. 
 
Fig. 1. Illustration of lung images, preprocessed results of infected lesions and lung fields on 3 CAP (left 3 columns) and 3 COVID-19 patients (right 
3 columns), respectively. 
B. Preprocess of Lung Infections and Fields   
We propose to utilize the disease characteristics, i.e., 
infection locations and spreading patterns, to extract 
handcrafted features. To do that, we automatically segmented 
infected lung regions and lung fields bilaterally. The infected 
lung regions were mainly related to manifestations of 
pneumonia, such as mosaic sign, GGO, lesion-related signs 
(air bronchogram), and interlobular septal thickening. The 
resulting lung fields include left and right lungs, five lung 
lobes, and eighteen pulmonary segments. 
The segmentation process was done through our in-house 
research portal software[14]. Specifically, a deep learning 
based network called VB-Net was employed for image 
segmentation. The VB-Net is a modified network that 
combines V-Net with bottleneck layers to reduce and 
combine feature map channels[15]. The network includes a 
contracting path to extract global image features and an 
expansive path to integrate fine-grained image features. A 
bottleneck structure is integrated in the network to reduce the 
number of feature map channels and thus speed up the spatial 
convolution. Given proper annotations as training data, the V-
Net is capable of segmenting infected lesions as well as lung 
fields. This software has been evaluated in segmentation of 
infections and lung fields and achieved Dice similarity 
coefficient of 92% between automated and manual infection 
segmentations. In this work, we directly use this software for 
segmentation of infected lesions and lung fields. 
An example of images and preprocessed results is shown 
in Fig. 1. A total of 3 CAP and 3 COVID-19 patients are 
included in 6 columns, respectively. Segmentations of 
infected lesions and lung fields are also shown.  
C. Infection Size Distribution and Proposed Size-Aware 
Method  
We refer the infection size as the volume of infected 
regions against the volume of whole segmented lung. Fig. 2A 
shows the distribution of infection size in patients. As the 
relationship between size and disease progress is not linear, 
we also tried to separate patients into 4 groups, based on 
exponential intervals. Results show that Fig. 2B can better 
separate the patients. As can observe that, COVID-19 patients 
in our dataset tend to have larger infections. For example, 
they account for 96% (538 vs. 20) in the size group of >10%. 
 
Fig. 2. Illustration of size distribution in patients. (A) shows a highly skewed 
distribution for the number of subjects as a function of infection size. (B) 
separates the dataset into 5 groups with exponential size ranges. 
 
Fig. 3. Flow chart of (A) the 5-fold cross validation, (B) train and test process in each fold, and (C) the proposed size-aware method.  
In contrast, CAP patients occupy 91% (309 vs. 30) in the size 
group of <0.01%.   
As above mentioned, such polarized patient distribution is 
not ideal for conventional classification models. In these 
models, size would be chosen as a major feature as it could 
easily separate both groups, although this leads to a low 
performance for the classification of middle-size groups and 
does not reflect the real radiographic appearance differences 
between two types of pneumonia. In this work, we proposed 
a new classification strategy with its flow chart shown in Fig. 
3. In particular, all data were randomly partitioned to 5 
equally-sized subsamples. In each fold, 4 subsamples were 
used for training data to construct the classification model, 
and the rest one subsample was used as testing data. This 
process was repeated until all subsamples were tested. Fig. 
3B shows the schematic diagram where, in each fold, all 
images were preprocessed, and machine learning models 
were trained including feature extraction, selection, and 
disease classification. In the testing stage, a new image would 
undergo the preprocessing steps, and then the model 
predicted its probability of being COVID-19 or CAP.  
Herein, we proposed an infection size-aware random 
forest (iSARF) method (Fig. 3C). From all features, the 
infection size was used as the only feature in a 3-level random 
forest where a decision tree was formed and used to separate 
the data into 4 size groups. Then a group of random forests 
were constructed for each size group in the training process. 
In the testing stage, the testing data would be sent to a proper 
size group through the decision tree and then classified by the 
following (respective) random forests for the final diagnosis. 
Details of feature extraction and classification are provided in 
the following subsections. 
D. Extraction of Location-Specific Features  
In this study, we proposed a series of handcrafted features 
to be automatically extracted in CT images from infections 
and lung fields. These features are composed of 4 categories, 
including the volume, infected lesion number, histogram 
distribution, and surface area. The detailed feature 
distribution framework is shown in Fig. 4.  
Volume features. We extracted the total volume of infected 
region, and calculated the percentage of the infected region 
of the whole lung. By using the lung field masks, we further 
extract the volume and percentage, respectively, in each lobe 
and pulmonary segment. As there is evidence that COVID-19 
more likely occur in both lungs, we calculate the infected 
lesion difference as well as the percentage difference between 
left and right lungs.  
Infected lesion number. Another image difference between 
COVID-19 and CAP is that most of COVID-19 infections 
encompassed bilateral lungs with multifocal involvement[8, 
16], and COVID-19 generally also has concentrated infected 
lesions while CAP shows small in volume and patchy in 
distribution[17]. Therefore, we calculate the characteristics of 
the total number of infected regions in the bilateral lungs, 
lung lobes, and pulmonary segments, respectively. 
Histogram distribution. The manifestations of COVID-19 
had its own characteristics, which are different from other 
types of pneumonia, such as Influenza-A viral 
pneumonia[13]. The predominant chest CT findings show 
that bilateral and peripheral GGO and consolidation were a 
radiologic hallmark of COVID-19[6, 18, 19]. GGO is a 
pattern of hazy increased lung opacity with preservation of 
bronchial and vascular margins, whereas consolidation is 
characterized by a homogeneous increase in lung 
parenchymal attenuation that obscures the margins of vessels 
and airway walls on CT image[17]. In order to extract CT 
intensity distribution of the infected region, we calculated the 
histogram features of the infected region. According to the 
window width of the lung window of 1500 and the window 
level of -600, the intensity value range of the lung region 
image obtained by inference tends to be between -1350 and 
150. According to the preset intensity value interval, we 
divided the interval into 30 equal bins, and counted the 
frequency of intensity level in the infected region at each bin 
to obtain the frequency distribution histogram features.  
 
Fig. 4. Illustration of the extraction of handcrafted image features. There are totally 96 features, including 26 volume features, 31 number features, 
32 histogram features, and 7 surface features.  
Surface area. Compared with CAP, it has been found that 
COVID-19 had a predominate distribution in the posterior 
and peripheral lung[20], and the abnormalities of lung 
parenchyma eventually spread to the central area and bilateral 
upper lobes[8]. Therefore, we constructed the infection 
surface as well as the lung boundary surface. We further 
calculated the distance of each infection surface vertex to the 
nearest lung boundary surface, and categorized them into 5 
ranges, as 3, 6, 9, 12, and 15 voxels (voxel spacing is 1.5mm). 
For features, the number of infection surface vertices within 
each range of distances to the lung wall were calculated. 
Furthermore, the percentage of infection vertex number 
against the number of whole infection surface vertices in each 
range were also obtained.  
E. Feature Selection and Prediction  
After generating the features, we apply machine-learning 
methods to select proper features, and predict COVID-19 
patients from CAP patients. The feature selection and 
prediction process of each fold are detailed as follows. 
In the training stage, we employed least absolute shrinkage 
and selection operator (LASSO) to explore the optimal subset 
of clinico-radiological features for the classification, due to 
its ability to provide variable importance and interpretability. 
After that, the selected features were fed into LR, SVM, NN, 
and the proposed method, respectively, to determine their 
hyperparameters for disease diagnosis. For LR, we used with 
default parameters of penalty as L2 (the norm used in the 
penalization) and regularization C as 1. For SVM, we used 
radial basis function (RBF) kernel with parameters of 
regularization C and gamma being determined through an 
inner 5-fold grid search. For NN, we used MLP Classifier 
with one hidden layer of 100 nodes and with max iterations 
of 500. For the proposed method, 100 trees of random forest 
were used for each size group, maximum depth of tree is 10, 
and Gini impurity is employed to measure the quality of a 
split. These trained models were then applied to new test 
images to predict their probability of being COVID-19 
against CAP in the testing stage.  
To evaluate the performance, receiver operating 
characteristic (ROC) analysis was performed. Sensitivity 
evaluates the ratio of correctly identified positive cases versus 
all positive cases. Specificity measures the ratio of negatives 
correctly found in all true negatives. Area under the curve 
(AUC) demonstrates the ability of classifier in consideration 
of both sensitivity and specificity. The most weighted 
features were listed. We further investigated the metrics of 
results with respect to the infected lesion size. 
III. RESULTS 
The dataset includes 1658 patients with COVID-19 and 
1027 patients with CAP. The age and gender distribution of 
all subjects are shown in Fig. 5. The age of COVID-19 
subjects is 49±14 years, which is significantly younger than 
that of CAP subjects as 56±14 years (p<0.001 with two-
sample t-test). There are 856 males and 802 females in 
COVID-19, which shows slightly higher male to female ratio 
than the CAP with 486 males and 541 females (p=0.038 
through Chi-square test). 
We developed a machine learning framework to 
automated process the CT images, extract features, and 
classification of COVID-19 from CAP patients. The 
proposed method, named infection size-aware random forest 
(iSARF), includes a 3-level decision tree to separate subjects 
into different groups based on the size of infected lesions, and 
followed by random forests for classification in each group. 
The performance of the proposed method was evaluated 
through a 5-fold cross-validation. Comparison methods 
include logistic regression (LR), support vector machine 
(SVM), and neural network (NN). The mean ROC was 
averaged from the 5 folds. Results are shown in Fig. 6. In 
particular, the proposed method demonstrates an overall 
superior ROC curve, with the highest AUC of 0.942. Fig. 6B 
shows the details of metrics, and the proposed method obtains 
the best performance with sensitivity of 0.907, specificity of 
0.833, and accuracy of 0.879. The LR and NN methods 
perform similarly, and SVM has relatively lower 
performance.  
We further broke down the whole dataset into 5 size groups 
to better evaluate the performance of methods. Results reveal 
that, although overall accuracy seems high in the size group 
of <0.01%, all methods actually have low sensitivity, which 
means the COVID-19 patients with small infections (most 
likely in early stage) are quite difficult to be detected. 
Similarly, all methods show low specificity in the size group 
of >10%, which suggests the subjects with large infections 
would be mainly treated as COVID-19. This suggests that, 
the studies that report only overall performance such as Fig. 
6B would easily be biased due to the imbalanced distribution 
of infected lesion sizes. For the remaining groups, the overall 
 
Fig. 5. Distributions of (A) age and (B) gender for the 2685 subjects. 
 
Fig. 6. Illustration of (A) the mean ROC curves from 5 folds in different 
classifiers, (B) overall performance, and (C) performance after dividing into 
5 groups. SEN means sensitivity, SPE means specificity, ACC means 
accuracy, and AUC means area under curve. 
screening performance increases gradually as the infected 
lesion size becomes larger. For example, accuracy increases 
from 0.753, 0.819 to 0.907 in the groups of 0.01-0.1%, 0.1-
1%, and 1-10%. The individual classification results of the 
proposed method are also shown in Fig. 7. It could be 
observed that the sensitivity to screen COVID-19 still have a 
relatively low performance and needs to be improved 
especially in the small size groups, e.g., <0.01% and 0.01-
0.1%.  
The features picked mostly by the proposed method were 
shown in Fig. 8. Note that they are weighted by the times of 
being picked in 5 folds. Results show that the volume and 
number features are mostly from the lung segments, and 
several features are from the lung lobes and overall 
asymmetry. Histogram features are largely selected including 
many bins, and surface features focus on the short range as 3 
and 6 voxels.   
IV. DISCUSSION  
Positive results of nucleic acid-based laboratory testing are 
still the diagnosis standard of COVID-19. Nevertheless, 
laboratory testing was also reported time-consuming and 
having a high false-negative rate, and thus CT imaging is 
suggested as a complementary tool or even recommended 
approach to the COVID-19 screening in China. A recent 
study compared RT-PCR results with chest CT scans in 1014 
subjects, and found that chest CT scans achieved high 
sensitivity of 97%, low specificity of 25%, and accuracy of 
68%. However, the performance could potentially be 
improved if the chest CT reading could leverage advanced 
image analysis techniques. In this study, we proposed a 
machine learning method with COVID-19 specific features to 
explore the potential application of CT-based COVID-19 
screening. Results are promising, showing 90.7% sensitivity, 
83.3% specificity, and 87.9% accuracy. These findings 
suggest that the proposed method could effectively assist the 
screening of COVID-19 from CAP. 
To date, there is few reported study on machine learning 
based COVID-19 CT image analysis yet. Wang et al. reported 
a disease screening framework using deep learning method 
with sensitivity of 74% and specificity of 67%, in a total of 
44 COVID-19 patients and 55 typical viral pneumonia 
patients[12]. Xu et al. studied the early screening of COVID-
19 from Influenza-A viral pneumonia and healthy cases with 
totally 618 CT samples[13]. Li et al. performed a study on 
screening among 468 COVID-19, 1511 CAP, and 1303 non-
pneumonia patients. Shi et al. presented machine learning 
model to classify severe patients from non-severe group, 
where 45 severe cases and 151 non-severe were involved[21].  
One of compelling findings of the current study is the 
unbalanced distribution of infection size between COVID-19 
and CAP patients. In accordance with the previous reports[8, 
19, 22], the observation regarding the high prevalence of 
bilateral and peripheral lung opacities, multiple lobular and 
subsegmental areas infections, and multifocal involvement is 
the most typical findings on CT images of COVID-19 
patients. For example, COVID-19 pneumonia tends to 
manifest on CT images as bilateral and a slight predominance 
in the right lower lobes with the mean involved lung segment 
number of 10.5[3]. Besides, multifocal involvement was 
more common than unifocal involvement in COVID-19 
patients[8]. In the present study, we proposed a size-aware 
and location-specific machine learning framework. The 
proposed method first separated the cohorts into different size 
groups through the decision tree, thus reducing the bias of 
infection size. From 5-fold experiments, the obtained 
decision trees show that, when separating the dataset into 4 
groups, consistent thresholds around 0.01%, 0.3%, and 7% 
could be obtained (supplementary material Fig. S1). The 
feature weight analysis further shows that few size related 
features were chosen by the proposed method. Therefore, our 
findings emphasize the importance of percentage of infected 
lesion in the prediction of COVID-19 pneumonia. Meanwhile, 
we also compared the current handcrafted features in this 
study with Radiomics features extracted directly from 
 
Fig. 7. Illustration of predicted probability with classification labels for 
different size groups by using the proposed method. 
 
Fig. 8. Illustration of features mostly picked in the proposed model. 
infected lesions. Results show that, using Radiomics features 
alone, the proposed method has lower performance (2.4% in 
accuracy) than that of handcrafted features. By combing the 
Radiomics with handcrafted features, the performance of the 
proposed method slightly improved (0.6% in accuracy) 
(supplementary material Fig. S2).  
A few limitations still exist in this study. First, no 
pneumonia-related clinical characteristics was available to 
examine the correlation between symptoms and radiologic 
findings. Including more clinical characteristics might 
advance our ability to better describe our radiologic findings 
of COVID-19 pneumonia. Second, only baseline CT findings 
of COVID-19 patients that clinicians and radiologists first 
encountered were included, rather than findings from follow-
up CT scans. Therefore, a follow-up study of the disease 
progression is needed in future work. Third, the symptom 
severity of COVID-19 and differential diagnosis of 
pneumonia subtypes were not included in this study, which 
warrants further investigation.  
It is worth noting that the proposed method has been 
integrated into uCloud platform as an online service and 
available to over 20 clinical facilities in China to date. 
Meanwhile, our research portals that include computer 
hardware such as GPUs and software have been deployed and 
used in over 50 hospitals, in which over 20 are in Wuhan, 
China.  
In conclusion, CT imaging demonstrates high accuracy 
through machine learning technique and thus could be an 
efficient tool for COVID-19 screening. The infection size 
bias needs to be considered in both the method development 
and the result evaluation process.  
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Results of decision trees in the proposed method 
In each fold, one 3-level decision tree was obtained (Fig. S1). The size of infected lesion was the only feature to automatically 
decide the split threshold in each node to separate the dataset into two groups. For example, in fold 1, a size threshold of 0.27% 
was chosen to separate all the training data in this fold into two groups. Then, these smaller size group was again separated by a 
size threshold of 0.01%. The larger size group was separated by a size threshold of 7.4%. Overall, the thresholds in all 5 folds are 
in the similar range.  
 
 
Fig. S1. Results of decision tree of the proposed method in 5 folds.  
Evaluation of the added value of Radiomics features  
A set of 93 Radiomics features were automatically extracted for each subject from the infected lesion from the intensity image. 
The features include 19 first-order intensity statistics (e.g., average gray level intensity, range of gray values), and 74 texture 
features (e.g., gray level co-occurrence matrix, gray-level run-length matrix, gray-level size-zone matrix, and neighborhood gray-
tone difference matrix).  
We compared the performance of using the proposed method with 1) proposed handcrafted features, 2) Radiomics features only, 
and 3) combined handcrafted and Radiomics features. Fig. S2A shows that, the method with handcrafted features has 2% higher 
AUC than that using Radiomics features. By combining them together, the AUC is slightly increased for 0.4%. In Fig. S2B, the 
method with both features has 0.4% lower sensitivity, 2.1% higher specificity, and 0.6% higher accuracy than the method with 
handcrafted features. The size group analysis found that the combined method shows around 2% accuracy improvement in the 
0.01~0.1% group and the 1~10% group.  
 
Fig. S2. Illustration of (A) the mean ROC curves from 5 folds in different feature sources, (B) overall performance, and 
(C) performance after dividing into 5 size groups. SEN means sensitivity, SPE means specificity, ACC means accuracy, 
and AUC means area under curve.  
